Illicium verum supplementation in patients with hypothyroidism
Phase 3
- Conditions
- Hypothyroidism.Other hypothyroidism
- Registration Number
- IRCT20141025019669N19
- Lead Sponsor
- Qazvin University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
Patients with hypothyroidism
Patient 20-50 years old
Having a body mass index less than 30
Consent signed by the patient
Exclusion Criteria
Pregnancy and lactation
Infectious diseases, Inflammatory diseases, Diabetes, Cancer
Taking antioxidant supplements in the last three months
Drug use over the past three months, including diabetes, glucocorticoids, lipid-lowering drugs, and weight-loss drugs
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Thyroxine hormone. Timepoint: Before the intervention and after the intervention. Method of measurement: ELISA.;Triiodothyronine hormone. Timepoint: Before the intervention and after the intervention. Method of measurement: ELISA.;Thyroid-stimulating hormone. Timepoint: Before the intervention and after the intervention. Method of measurement: ELISA.;Total antioxidant capacity. Timepoint: Before the intervention and after the intervention. Method of measurement: ELISA.;Malondialdehyde. Timepoint: Before the intervention and after the intervention. Method of measurement: ELISA.;Depression Anxiety and Stress. Timepoint: Before the intervention and after the intervention. Method of measurement: Depression Anxiety and Stress Scale (DASS-21).
- Secondary Outcome Measures
Name Time Method Body mass index. Timepoint: Before the intervention and after the intervention. Method of measurement: Using the formula (weight in kilograms divided by height in meters squared).